Who Protects People from Asbestos Exposure Today?

Today, the public is well aware of the dangers of asbestos, but that doesn’t guarantee that they are safe. Many domestic and international agencies have been established with the specific purpose of protecting people from exposure to asbestos and other toxic materials. These regulatory organizations are essential to the safety of workers, as well as others

What to Expect if You Opt Out of Mesothelioma Treatment

Mesothelioma is a rare and aggressive form of cancer caused by exposure to asbestos. The disease has proven to be extremely resistant to traditional cancer treatments and is always considered fatal. Though many patients choose aggressive treatment to extend their survival, not all do. Some patients choose a path of palliative care, which helps them manage symptoms and maintain

Scottish Scientists to Explore Mystery of Mesothelioma’s Long Latency

One of the most challenging aspects of malignant mesothelioma is the significant amount of time that elapses between exposure to asbestos and the disease beginning to make itself known. The disease’s long latency period means that symptoms often don’t arise until fifty or sixty years later, and by the time it is diagnosed, it is

Asbestos in Makeup

When people think of asbestos, they picture high-heat or friction work settings and deteriorating insulation, not cosmetics. But in recent years, it’s come to light that the talc that is a core ingredient of makeup and personal products is frequently contaminated with the carcinogenic material, putting countless adults and children at risk for malignant mesothelioma and other serious

Study Highlights Benefits of Heated Chemotherapy for Pleural Mesothelioma 

Malignant mesothelioma is a rare and deadly form of cancer caused by exposure to asbestos. The disease can appear in the pleural cavity, the peritoneal cavity, and extremely rarely in the pericardial cavity. Administering heated chemotherapy after tumor removal surgery has proven to be extremely effective in patients with peritoneal mesothelioma, and now researchers say

European Agency Signals Approval for Keytruda for First-line Mesothelioma Treatment

Weeks after the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) plus pemetrexed and platinum-based chemotherapy for the frontline treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a similar endorsement, signaling its approval of the drug for use

Study Highlights Gut Bacteria’s Impact on Mesothelioma Treatment

Medical professionals in the United Kingdom are investigating whether mesothelioma patients’ intestinal ecosystem of mesothelioma patients plays a role in their response to immunotherapy. In preliminary investigations, researchers from the University of Leicester sequenced the genetic code of patients’ gut bacteria to determine whether there was a relationship between the two.

Pennsylvania Couple Win $3.8 Million Mesothelioma Verdict 

Harry Chirdon was diagnosed with malignant mesothelioma after a lifetime of having worked as a boilermaker. He and his wife filed a personal injury lawsuit against his former employer, Foster Wheeler, charging the company with neglecting to protect its employees from being exposed to asbestos. An Allegheny County jury agreed and awarded the company to

Recall of Asbestos-contaminated Baby Powder Raises Fear of Mesothelioma

A New Jersey-based medical supply company has issued a recall on 62 cases of asbestos-contaminated baby powder sent to distributors in 12 states, raising concerns over exposure that can lead to malignant mesothelioma and other asbestos-related diseases. The contamination was discovered during a sample testing conducted by the U.S. Food and Drug Administration (FDA).

FDA Approves Pembrolizumab Plus Chemotherapy for Unresectable Pleural Mesothelioma

The U.S. Food and Drug Administration has officially approved the use of Pembrolizumab (Keytruda) plus Pemetrexed and platinum chemotherapy as the frontline treatment for patients diagnosed with unresectable advanced or metastatic malignant pleural mesothelioma. The decision was based on data from a study that showed the combination provided significant improvement in overall survival versus chemotherapy

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now